Browse treatments

…ponse in the myocardium and cytokine-mediated damage, requiring targeted therapy. Genetic pathogenic mutations in desmoplakin and other desmosom…

… coronary arteries (ANOCA) is often managed conservatively with antianginal therapy. However, for unremitting ANOCA, the ESC guidelines give a clas…

…s were consistently highD. Despite frequent ED re-presentation, targeted therapy was recorded in fewer than a third of patients (correct)Abstrac…

… (iCCA) and 26.7% with other localisations), and 11.4% received targeted therapy (15.5% with iCCA and 2.5% with other localisations). No signifi…

…ctive analysis of patients with malignant melanoma who received immunotherapy at our institution. Real world treatment patterns, irAE, and ou…

…e clinical feasibility of personalised approaches.169Conclusion TIL therapy has been shown to be an effective strategy for the treatment of…

…ciplinary tumour board discussion, the patient was initiated on targeted therapy with crizotinib, with planned reassessment for surgical resecti…

…nts receiving chemotherapy, immunotherapy, targeted therapy, or hormone therapy. The same 31-item questionnaire used in a 2017 baseline study w…

…ysis highlighted a GOF heterozygous mutation in the STAT3 gene. Targeted therapy with Janus kinase inhibitor (tofacitinib) led to significant cl…

… results suggest claudin18.2 might be a potential biomarker for targeted therapy on lung mucinous adenocarcinoma, cholangiocarcinoma, colorectal…

…stroma to sensitise microsatellite stable colorectal tumours to immunotherapy.…

…tissue is integral to the delivery of personalised medicine and targeted therapy. NGS on liquid biopsy, a much less invasive technology, is an e…